These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Selenium compounds regulate p53 by common and distinctive mechanisms. Smith ML; Lancia JK; Mercer TI; Ip C Anticancer Res; 2004; 24(3a):1401-8. PubMed ID: 15274301 [TBL] [Abstract][Full Text] [Related]
3. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Spallholz JE; Palace VP; Reid TW Biochem Pharmacol; 2004 Feb; 67(3):547-54. PubMed ID: 15037206 [TBL] [Abstract][Full Text] [Related]
4. Apoptotic cellular events for selenium compounds involved in cancer prevention. Rikiishi H J Bioenerg Biomembr; 2007 Feb; 39(1):91-8. PubMed ID: 17549643 [TBL] [Abstract][Full Text] [Related]
5. Cancer chemoprevention: selenium as a prooxidant, not an antioxidant. Drake EN Med Hypotheses; 2006; 67(2):318-22. PubMed ID: 16574336 [TBL] [Abstract][Full Text] [Related]
6. Selenium: from cancer prevention to DNA damage. Letavayová L; Vlcková V; Brozmanová J Toxicology; 2006 Oct; 227(1-2):1-14. PubMed ID: 16935405 [TBL] [Abstract][Full Text] [Related]
7. Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. Zeng H; Combs GF J Nutr Biochem; 2008 Jan; 19(1):1-7. PubMed ID: 17588734 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compounds. Ramoutar RR; Brumaghim JL Cell Biochem Biophys; 2010 Sep; 58(1):1-23. PubMed ID: 20632128 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of mammary cancer chemoprevention by organoselenium compounds. El-Bayoumy K; Sinha R Mutat Res; 2004 Jul; 551(1-2):181-97. PubMed ID: 15225592 [TBL] [Abstract][Full Text] [Related]
10. Activities of structurally-related lipophilic selenium compounds as cancer chemopreventive agents. Ip C; Lisk DJ; Ganther HE Anticancer Res; 1998; 18(6A):4019-25. PubMed ID: 9891440 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic aspects of the interaction between selenium and arsenic. Zeng H; Uthus EO; Combs GF J Inorg Biochem; 2005 Jun; 99(6):1269-74. PubMed ID: 15917080 [TBL] [Abstract][Full Text] [Related]
12. Making sense of sex and supplements: differences in the anticarcinogenic effects of selenium in men and women. Waters DJ; Chiang EC; Cooley DM; Morris JS Mutat Res; 2004 Jul; 551(1-2):91-107. PubMed ID: 15225584 [TBL] [Abstract][Full Text] [Related]
13. Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium. Ohta Y; Suzuki KT Toxicol Appl Pharmacol; 2008 Jan; 226(2):169-77. PubMed ID: 17988700 [TBL] [Abstract][Full Text] [Related]
14. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Ganther HE Carcinogenesis; 1999 Sep; 20(9):1657-66. PubMed ID: 10469608 [TBL] [Abstract][Full Text] [Related]
15. Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium. Jariwalla RJ; Gangapurkar B; Nakamura D Br J Nutr; 2009 Jan; 101(2):182-9. PubMed ID: 18549510 [TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects. Lu J; Jiang C Nutr Cancer; 2001; 40(1):64-73. PubMed ID: 11799926 [TBL] [Abstract][Full Text] [Related]
17. Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Weekley CM; Harris HH Chem Soc Rev; 2013 Dec; 42(23):8870-94. PubMed ID: 24030774 [TBL] [Abstract][Full Text] [Related]
18. [Selenium and cancer: from prevention to treatment]. Brozmanová J Klin Onkol; 2011; 24(3):171-9. PubMed ID: 21717786 [TBL] [Abstract][Full Text] [Related]
19. Selenium redox cycling in the protective effects of organoselenides against oxidant-induced DNA damage. De Silva V; Woznichak MM; Burns KL; Grant KB; May SW J Am Chem Soc; 2004 Mar; 126(8):2409-13. PubMed ID: 14982447 [TBL] [Abstract][Full Text] [Related]
20. Dimethyldiselenide and methylseleninic acid generate superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L-Se-methylselenocysteine. Spallholz JE; Shriver BJ; Reid TW Nutr Cancer; 2001; 40(1):34-41. PubMed ID: 11799920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]